|
|
Volumn 334, Issue 4, 2001, Pages 109-116
|
|
Tmolt4 leukemic type II isoform of IMP dehydrogenase as a target for 1,2,4-triazolidine-3,5-diones, 1-(1-(3-methylphenyl)ethylidineamino)-4,4-diethyl-3,5-azetidinediones, 3,5-isoxazolidinediones, and 4,4-disubstituted-3,5-pyrazolidinediones
a
|
|
Author keywords
Antimetabolites; Azetidinediones; IMPDH Type II inhibitors; Pyrazolidinediones; Triazolidinediones
|
|
Indexed keywords
1 [1 (3 METHYLPHENYL)ETHYLIDINEAMINO] 4,4 DIETHYL 3,5 AZETIDINEDIONE DERIVATIVE;
1,2,4 TRIAZOLIDINE 3,5 DIONE DERIVATIVE;
3,5 ISOXAZOLIDINEDIONE DERIVATIVE;
INOSINATE DEHYDROGENASE;
INOSINATE DEHYDROGENASE INHIBITOR;
ISOENZYME;
MERCAPTOPURINE;
MYCOPHENOLIC ACID;
PYRAZOLIDINE 3,5 DIONE DERIVATIVE;
RIBAVIRIN;
UNCLASSIFIED DRUG;
ANTINEOPLASTIC AGENT;
ENZYME INHIBITOR;
ARTICLE;
CANCER GROWTH;
CELL PROLIFERATION;
COMPETITIVE INHIBITION;
CONTROLLED STUDY;
DNA SYNTHESIS INHIBITION;
DRUG POTENCY;
ENZYME ACTIVITY;
ENZYME INHIBITION;
HUMAN;
HUMAN CELL;
LEUKEMIA CELL;
PRIORITY JOURNAL;
PURINE SYNTHESIS;
DRUG ANTAGONISM;
ENZYMOLOGY;
PATHOLOGY;
T CELL LEUKEMIA;
ANTINEOPLASTIC AGENTS;
ENZYME INHIBITORS;
HUMANS;
IMP DEHYDROGENASE;
ISOENZYMES;
LEUKEMIA, T-CELL, ACUTE;
|
|
EID: 0034744372
PISSN: 03656233
EISSN: None
Source Type: Journal
DOI: 10.1002/1521-4184(200104)334:4<109::AID-ARDP109>3.0.CO;2-5 Document Type: Article |
|
Times cited : (6)
|
|
References (22)
|
